QIAGEN Receives FDA EUA for Rapid COVID Test
QIAGEN has received emergency use authorization (EUA) from the FDA for its QIAreach SARS CoV-2 Antigen Test.
Read MorePosted by Chris Wolski | Aug 10, 2021 | Covid 19, Rapid Assays |
QIAGEN has received emergency use authorization (EUA) from the FDA for its QIAreach SARS CoV-2 Antigen Test.
Read MorePosted by Chris Wolski | Aug 9, 2021 | Covid 19 |
cPass zeros in on the exact subsect of antibodies that block the virus from attacking a patient’s cells and how protected they are.
Read MorePosted by Chris Wolski | Aug 6, 2021 | Covid 19, Rapid Assays |
Acupath is part of a select group of laboratory providers in the greater NYC area meeting the COVID-19 testing needs for international travel.
Read MorePosted by Chris Wolski | Aug 6, 2021 | Covid 19 |
Engineers have designed a tabletop device that can detect COVID-19 from a saliva sample in about an hour, and is as accurate as PCR tests.
Read MorePosted by Chris Wolski | Aug 6, 2021 | Information Technology |
Lab stewardship programs can help with decision making and actionable insights for the right testing decisions and better quality outcomes.
Read More